American Century Companies’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $861K | Buy |
134,380
+27,366
| +26% | +$175K | ﹤0.01% | 2347 |
|
|
2025
Q1 | $379K | Buy |
107,014
+47,704
| +80% | +$169K | ﹤0.01% | 2606 |
|
|
2024
Q4 | $224K | Buy |
59,310
+38,261
| +182% | +$145K | ﹤0.01% | 2764 |
|
|
2024
Q3 | $68.2K | Buy |
21,049
+2,008
| +11% | +$6.51K | ﹤0.01% | 2852 |
|
|
2024
Q2 | $36.2K | Sell |
19,041
-359,757
| -95% | -$684K | ﹤0.01% | 2870 |
|
|
2024
Q1 | $1.08M | Sell |
378,798
-163,748
| -30% | -$465K | ﹤0.01% | 2119 |
|
|
2023
Q4 | $7.99M | Buy |
+542,546
| New | +$7.99M | 0.01% | 1237 |
|